Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer.

Published in: Korean journal of clinical oncology (2022)

APE1 could be considered a prognostic factor in colon cancer patients treated with oxaliplatin-based chemotherapy.

Keyphrases